Suzanne Bruhn Made President and Chief Executive Officer of Promedior, and a Member of its Board of Directors

Promedior, Inc., a clinical stage biotechnology company, appointed Suzanne L. Bruhn, Ph.D., President and Chief Executive Officer, and a Member of its Board of Directors. Suzanne, who holds a PhD in Chemistry from MIT and was a Postdoctoral Fellow in the Department of Human Genetics at Harvard Medical School, had been Senior Vice President, Strategic Planning and Program Management for Shire’s Human Genetic Therapies division. Read more in the Business Wire press release.